International Clinical Trial: Protocol: EXPD-101-201 - A Study to Learn More About How Well a Medicine Called EXPD-101 Works and How Safe it is in Participants with the Long Term Lung Disease, COPD

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (PACTR202609911768910) titled 'Protocol: EXPD-101-201 - A Study to Learn More About How Well a Medicine Called EXPD-101 Works and How Safe it is in Participants with the Long Term Lung Disease, COPD' on Sept. 11.

Study Type: Interventional

Study Design: Parallel: different groups receive different interventions at same time during study,Randomised,Stratified allocation where factors such as age, gender, center, or previous treatment are used in the stratification,Allocation was determined by the holder of the sequence who is situated off site

Primary Sponsor: Expedition Therapeutics Inc.

Condition: Respiratory Respiratory

Interventi...